Low yield of population-based screening for Type 2 diabetes in the Netherlands:the ADDITION Netherlands study by Janssen, P. G. H. et al.
  
 University of Groningen
Low yield of population-based screening for Type 2 diabetes in the Netherlands





IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2007
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Janssen, P. G. H., Gorter, K. J., Stolk, R. P., & Rutten, G. E. H. M. (2007). Low yield of population-based
screening for Type 2 diabetes in the Netherlands: the ADDITION Netherlands study. Family practice, 24(6),
555-561. https://doi.org/10.1093/fampra/cmm052
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
 The Author 2007. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org.
doi:10.1093/fampra/cmm052 Family Practice Advance Access published on 25 October 2007
Low yield of population-based screening for Type 2
diabetes in the Netherlands: the ADDITION
Netherlands study
PGH Janssena, KJ Gortera, RP Stolkb and GEHM Ruttena
Janssen PGH, Gorter KJ, Stolk RP and Rutten GEHM. Low yield of population-based screening
for Type 2 diabetes in the Netherlands: the ADDITION Netherlands study. Family Practice
2007; 24: 555–561.
Background. About 10 years ago, it was estimated that half of all people with diabetes were un-
recognized. Since then, according to the national guidelines, case finding for diabetes in general
practice has become common in the Netherlands, resulting in a substantial increase of the preva-
lence of known diabetes. Nevertheless, the need for population-based screening is advocated,
especially by the national federation of diabetes patients.
Objective. To evaluate the efficiency of population-based screening for Type 2 diabetes.
Methods. From 2002 to 2004, we performed a four-step screening procedure [questionnaire,
random glucose measurement, fasting glucose measurement and oral glucose tolerance test
(OGTT)] and a three-step procedure (without random glucose measurement) in 79 general prac-
tices in the southwestern region of the Netherlands.
Results. A total of 56 978 non-diabetic subjects, aged 50–70 years, were asked to complete the
questionnaire. Those with a score above threshold underwent further glucose testing. Eventu-
ally, 586 participants (1.0%) were diagnosed with Type 2 diabetes (in four-step procedure 285
subjects and in three-step procedure 301). Impaired glucose regulation was assessed in 1011
participants (1.8%). Dropout rate in the screening programme among participants who should
undergo an OGTT was 23.4%. The risk score was higher if glucose metabolism was more
disturbed.
Conclusion. In the Netherlands, the yield of population-based screening is low. The dropout
among high-risk individuals was high. Given the decreasing prevalence of undiagnosed dia-
betes and the possibility of opportunistic screening on a continuous basis, opportunistic screen-
ing for diabetes might be more appropriate than population-based screening. Further research
on this topic is needed.
Keywords. Case finding, general practice, opportunistic screening, population-based
screening, Type 2 diabetes.
Introduction
Diabetes mellitus is a worldwide rapidly increasing
disease.1 In the Netherlands, the prevalence of dia-
betes was about 3% in 2003.2 Because Type 2 diabetes
is often asymptomatic in its early stages, it may remain
undiagnosed for many years.3 At the time of diagnosis,
however, diabetic complications are frequently pres-
ent.4,5 In this context, screening for diabetes has be-
come a relevant issue. Early detection of diabetes
through screening might be beneficial, although defini-
tive evidence is lacking.6 Despite this, screening is rec-
ommended by the American Diabetes Association.7
Limited information is available regarding the opti-
mal methods for diabetes screening. Therefore, it is
disputable how we should screen for diabetes.8–11
Many screening programmes combine population-
based and targeted (directed at high-risk individuals)
strategies in order to enhance the yield.12 Mostly,
a stepped approach is chosen starting with a simple
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risk score to identify high-risk individuals but it is not
known how many steps are preferable in a screening
programme. The use of a risk score is attractive be-
cause it minimizes the number of persons who will at-
tend glucose measurement and therefore reduces
costs.13 Opportunistic screening or case finding in-
volves screening during routine encounters with the
health care system.
Guidelines from the Dutch College of General
Practitioners recommend case finding in several well-
defined categories of patients at high risk to have un-
diagnosed Type 2 diabetes (persons older than 45
years with close relatives with Type 2 diabetes, per-
sons with hypertension, an unfavourable lipid profile,
obesity or a history of cardiovascular diseases and per-
sons from specific ethnic minorities).14 The Health
Council of the Netherlands recently stated that there
is no indication to introduce general screening for dia-
betes without first demonstrating its effectiveness.15
To investigate whether early treatment of screen-
detected diabetic patients is beneficial, the ADDITION
study (Anglo-Danish-Dutch Study of Intensive Treat-
ment in People with Screen Detected Diabetes in
Primary Care) has been initiated.16 In the ADDITION
Netherlands study, we performed a four-step and a
three-step screening procedure. The aim of the present
study was to evaluate the yield of population-based
screening for diabetes in the Netherlands. Evaluation
took place on the following topics: the percentage of
people who showed up for diagnostic testing, the per-
centage of people diagnosed with diabetes and the
percentage of people who did not go through the




All 56 978 patients, aged 50–70 years and not known
to have diabetes, from 79 general practices in the
southwestern region of the Netherlands were invited
to participate in the screening programme. The study
was approved by the Medical Ethical Committee of
the University Medical Center Utrecht. Participants
gave written informed consent.
Practices
Forty-one practices participated in the first screening
procedure and 38 in the second. Before the screening
programme, the prevalence of known diabetes (in all
age groups) in the practices in the four-step and three-
step procedures was 3.2% and 3.0%, respectively.
Screening programme
Two stepwise population-based screening proce-
dures were performed. The first screening procedure
consisted of four steps and was carried out from May
2002 to January 2003. The second procedure (from
July 2003 to April 2004) consisted of three steps. As-
signment to a procedure was done on a geographical
basis. Practices closer to the regional laboratory par-
ticipated in the first screening procedure and practices
more distant to the laboratory in the second.
The invitation letter was sent to the patients’ home
addresses and signed by their own GP. In the Nether-
lands, practically the entire population is registered
with a GP. The letter explained the aim of the study
and enclosed an informed consent and a self-completed
questionnaire which contained questions about age,
gender, body mass index, family history of diabetes,
frequent thirst, use of anti-hypertensive medication,
shortness of breath, claudication and cycling. Our
questionnaire was a slightly modified version of the
Symptom Risk Questionnaire used in the Hoorn
study17,18 and attenuated the impact of age on the
score. (In our questionnaire participants in age groups
55–59, 60–64 and 65–69 years scored 1, 2 and 3 points,
respectively, whereas in the original version 2, 4 and 6
points were given.) The range of the score was 0–29
points. In the invitation letter it was stated emphatic-
ally that further testing was indicated only if the score
on the questionnaire was above threshold. However,
people with scores under threshold showing up for first
glucose measurement were not sent back home. Meas-
urements were performed on special sites in the neigh-
bourhood during and outside ordinary business hours.
If participants were unable to come at the given time,
they had the opportunity to show up on another day
in the same week, even on Saturday morning. If indi-
cated, subsequent testing took place in the week after
the first measurement. Participants were classified ac-
cording to the 1999 World Health Organization
(WHO) criteria.19 Capillary blood glucose values were
determined with a HemoCue B-Glucose Analyser
based on the glucose-dehydrogenase method.20 Plasma
glucose was measured using a peroxidase method.
Four-step screening procedure
The first step of the screening procedure consisted of
the questionnaire (Step 1). Participants with a score
>4 points were invited for a random blood glucose
(RBG) measurement (Step 2). As a matter of fact,
the first procedure was designed not only to screen for
Type 2 diabetes but also for impaired glucose toler-
ance (IGT). Therefore, the cut-off point was 2 points
lower than in the second procedure (see three-step
screening procedure). If RBG >5.5 mmol/l, a fasting
blood glucose (FBG) was measured (Step 3). Partici-
pants with an RBG >11.1 mmol/l and FBG >6.0
mmol/l were diagnosed as diabetic patients. Those with
FBG >6.0 mmol/l but RBG <11.1 mmol/l were invited
for further diagnostic testing by means of a standard
75-g oral glucose tolerance test (OGTT) (Step 4). In
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these subjects, diagnosis of diabetes was established if
fasting plasma glucose (FPG) or post-load plasma glu-
cose (2-hour PG) in the OGTT was >7.0 mmol/l or
>11.1 mmol/l, respectively. Subjects who did not
achieve a diabetic value in the OGTT were defined as
having ‘epidemiological diabetes’ based on their dia-
betic FBG. Participants whose FBG concentration was
>5.2 mmol/l and <6.0 mmol/l also underwent an
OGTT. If these subjects had 2-hour PG >11.1 mmol/l
in the OGTT (their first diabetic glucose value), a sec-
ond OGTT was performed. Subjects with 2-hour PG
>7.8 mmo/l but <11.1 mmol/l were defined as having
IGT. Participants with 2-hour PG <7.8 were classified
as having impaired fasting glucose (IFG) if FBG >5.6
mmol/l and <6.0 mmol/l or if FPG >6.1 and <7.0
mmol/l. Finally, a letter with the test results was handed
over to all participants and the implications were dis-
cussed. In addition, participants’ GPs were informed.
Three-step screening procedure
Because of costs, in this procedure only capillary
blood samples were taken, and glucose measurements
outside ordinary business hours and on Saturday were
skipped. Participants with a score >6 points on the
questionnaire (Step 1) were invited for FBG measure-
ment (Step 2). RBG measurement was not performed.
If FBG >6.0 mmol/l, a capillary OGTT followed (Step
3). In case of at least one diabetic value in the OGTT,
subjects were diagnosed as having diabetes; otherwise,
epidemiological diabetes was established. Subjects
with FBG >5.6 mmol/l and >6.0 were classified as
having IFG, they did not undergo an OGTT.
Data analysis
Statistical analyses were performed using SPSS for
Windows (version 11.0). To compare characteristics of
participants and procedures Student’s t-test and chi-
square test were used. Characteristics of practices in
both procedures were analysed with chi-square test.
The association between risk score and different glu-
cose tolerance categories was analysed using linear re-
gression. A P-value <0.05 was considered significant.
Results
Of all 56 978 participants, 17 883 showed up to un-
dergo glucose testing. Eventually, 586 subjects (1.0%
of the invited people) were diagnosed with Type 2 dia-
betes. Epidemiological diabetes was assessed in 222
participants (0.4%), impaired glucose regulation (IFG
and IGT) in 1011 subjects (1.8%). The dropout rate
in the screening programme among participants who
should undergo an OGTT was 23.4%. The prevalence
of known diabetes in people aged 50–70 years in the
practices before and after the screening was 6.1% and
7.0%, respectively.
Four-step screening procedure
Of the 29 251 invited subjects, 11 028 (37.7%) under-
went RBG measurement (Fig. 1). FBG was measured
in 3243 individuals (11.1%). Eventually, 285 individu-
als (1.0% of the invited people) were diagnosed with
Type 2 diabetes. In addition, we classified 175 subjects
(0.6%) with IGT and 218 (0.7%) with IFG. In 126 sub-
jects (0.4%) epidemiological diabetes was established.
After RBG measurement, a total of 323 (9.1%) sub-
jects eligible for FBG measurement did not show up.
Of the 747 subjects with FBG >5.2 mmol/l and <6.0
mmol/l, 180 (24.1%) did not undergo the OGTT.
Among all 462 people who should have an (second)
OGTT, 126 subjects (27.3%) dropped out.
A total of 1467 subjects (5.0% of the invited people)
attended RBG measurement, although their risk score
did not entitle them further testing. Of those, 19 people
were classified as having diabetes, 7 as having epide-
miological diabetes, 12 as having IGT and 20 as having
IFG.
Three-step screening procedure
A total of 27 727 people were invited and 6855 sub-
jects (24.7%) showed up for FBG measurement (Fig. 2).
In 397 subjects, an OGTT was performed. In 301 par-
ticipants (1.1%), diagnosis of diabetes was established.
A total of 681 subjects (2.5%) were classified as hav-
ing IFG. A total of 96 subjects (0.3%) were classified
as having epidemiological diabetes. It was not possible
to diagnose IGT because an OGTT was performed
only in subjects with FBG >6.0 mmol/l.
Of the 489 subjects who were invited for the OGTT,
92 subjects (18.8%) dropped out. In the second proce-
dure, 1451 subjects (5.2% of the invited people) at-
tended FBG measurement, although their risk score
was under threshold. Of those, 43 subjects were classi-
fied as having diabetes, 8 as having epidemiological
diabetes and 70 as having IFG.
Both screening procedures compared
Characteristics of the two screening procedures are
presented in Table 1. The yield of both procedures
was similar. In the four-step procedure the yield was
1.0% (screen-detected diabetic patients as a proportion
of invited subjects) and that in the three-step proce-
dure 1.1%. When we calculated these percentages
after excluding the detected diabetic patients with
risk scores under threshold, we found 0.9% in both
procedures.
We calculated the mean risk scores (±SD) for each
diagnostic category. In the four-step procedure, the
risk score in those subjects attending the screening
with normal glucose tolerance (NGT) was 7.5 (±4.3).
Those with IFG, IGT and epidemiological diabetes
scored 8.5 (±4.9), 8.9 (±4.5) and 9.8 (±5.2), respec-
tively. The risk score of diabetic patients was 10.5 ±
5.0. In the three-step procedure risk scores were as
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follows: 8.0 (±4.1) (NGT), 9.2 (±4.2) (IGT), 10.0 (±4.2)
(epidemiological diabetes) and 10.3 (±4.7) (Type 2 dia-
betes). In both screening procedures the risk score
proved to be higher if glucose metabolism was more
disturbed (test for trend: P < 0.001).
Comparing the 41 practices in the four-step proce-
dure with the 38 practices in the three-step procedure,
we found 22 (53.7%) and 15 practices (39.5%), respec-
tively, to be single-handed (P = 0.207).
Of the practices in the four-step procedure, 48.8%
was rural, while this percentage in the three-step
procedure was 68.4% (P = 0.077). In the four-step
procedure, five practices participated with >10% pa-
tients from ethnic minority groups and 1 practice in
the three-step procedure (P = 0.109).
Discussion
One-third of the invited persons attended first glucose
measurement which is comparable with the findings in
the Dutch Hoorn study.17 Approximately a quarter of
FIGURE 1 Outline of the four-step screening procedure. Between dotted lines: patients who did not show up. Asterisk indicates
secondOGTT for subjects with 5.2mmol/l<FBG< 6.0mmol/l, first OGTT for those with FBG >6.0mmol/l and RBG<11.1mmol/l
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the participants, invited for the OGTT, did not show up.
The yield of our population-based diabetes-screening
programme was low (1.0% of the invited people was
diagnosed with diabetes). In addition, the yields in the
four-step and three-step procedures were not signifi-
cantly different (1.0% and 1.1%, respectively).
Some limitations regarding the comparison of
the two screening procedures need to be taken into
consideration. Firstly, a considerable number of people
who might be at high risk for diabetes did not attend
the screening at all. However, since dropout rates
were high among high-risk individuals within both
screening procedures, it is unlikely that the compari-
son is distorted. Secondly, it cannot be excluded that
temporal trends influenced the yield of screening since
both screening procedures were performed succes-
sively. But a strong influence is unlikely because in
the screening period no new diabetes-screening guide-
lines were launched. Moreover, characteristics of
patients and practices in both procedures were com-
parable. Thirdly, the comparison between the yields of
the two procedures may be distorted because of differ-
ent methods of diagnosing. In the four-step procedure,
all participants underwent plasma glucose measure-
ment as well as capillary blood glucose measurement.
In the three-step procedure diagnosis of diabetes was
based on only capillary samples. However, the WHO
does not set plasma glucose measurement as the gold
standard for diagnosis of diabetes and allows the use
of capillary samples. Although there is debate on the
degree of concordance,21 Sandbaek et al.22 found both
tests to produce equivalent ascertainment of the
prevalence of confirmed diabetes. Furthermore, in the
four-step procedure some people were diagnosed with
diabetes without having an OGTT. There is
FIGURE 2 Outline of the three-step screening procedure. Between dotted lines: patients who did not show up












Gender (male %) 44.7 45.1 0.595
Age (years) (±SD) 59.5 ± 5.4 60.1 ± 5.7 –a
Risk score (patients) (±SD) 7.7 ± 4.4 8.2 ± 4.2 –a
Glucose measurement
RBG measurement (n) 11 028 –
FBG measurement (n) 3243 6855
OGTT measurement (n) 903 397




NGT (n) 9595 5685
IFG (n) 218 681
IGT (n) 175 –
Epidemiological diabetes (n) 126 96
Type 2 diabetes (n) 285 301
Screen-detected diabetic
patients as a proportion
of invited subjects (%)
1.0 1.1 0.188
Screen-detected diabetic




Epidemiological diabetes, one diabetic glucose value.
aResult of different selection criteria.
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a possibility that these differences in used algorithms
and methods of diagnosing influenced the yields of
screening.
We found an increase of 0.9% in the prevalence of
known diabetes after the screening programme. In the
Hoorn study (1989–1992) an increase of almost 5%
was reported, although the age group was a little dif-
ferent (50–75 years).23 The yield of the screening pro-
gramme in the Hoorn study, which was performed
from 1998 to 2000 in people aged 50–75 years, was
1.9% (screen-detected diabetic patients as a proportion
of invited subjects), which is almost twice as high as
the yield of our programme.17 In the mid-nineties of
the last century, it was estimated that about half of all
people with diabetes were undiagnosed, but we may
conclude that is no longer the case. Following recom-
mendations of the Dutch College of General Practi-
tioners screening for diabetes has become more
common in Dutch general practices in the last decade
which is reflected by a strong increase of the preva-
lence of diabetes in the late nineties.2 It should be
emphasized that the true prevalence of undiagnosed
diabetes remains unknown. Nevertheless, we may as-
sume that the low yield of our screening programme
was associated with the decreasing prevalence of un-
diagnosed diabetes.
In Denmark, Christensen et al.11 recently found only
0.6% screen-detected diabetic patients (between 40
and 70 years of age), mainly due to a large dropout
prior to entry into the screening programme. The
authors stated that population-based screening for dia-
betes is ineffective in general practice. In the English
part of the ADDITION study (Cambridge), high-risk
individuals for diabetes were initially identified by
a simple risk score using data routinely available in
general practice.24 In the UK, of the participants who
attended first glucose measurement, eventually 2.7%
were diagnosed with diabetes. In the ADDITION
Netherlands study, this percentage was 3.3%. These
findings suggest that the tool used in the UK and the
questionnaire in our screening procedure did not per-
form substantially different.
In our study, the dropout rates within the screening
programme were very high among subjects who should
undergo an OGTT, demonstrating the difficulties with
the OGTT in a screening programme. As non-response
frequently is selective, a higher prevalence of undiag-
nosed diabetes in the group of non-responders is quite
conceivable.
Against this background, one could argue that case
finding in general practice is possibly more suitable
for detecting unknown diabetes than population-based
screening. Conducting a screening programme is an
expensive and time-consuming process. Case finding,
incorporated in daily practice, is lacking these disad-
vantages. In the Netherlands, necessary conditions for
successful case finding are fulfilled: practically the
entire population is registered with a GP and general
practices are well organized with respect to daily dia-
betes care (involvement of practice assistants, practice
nurses and diabetes nurses in diabetes care). Addition-
ally, case finding seems more applicable than other
screening strategies in fulfilling the criterion that
screening should be a continuous process.25 Moreover,
we found that glucose intolerance is associated with
the height of the risk score: the higher the score, the
poorer the glycaemic control. This reveals another
possible advantage of case finding: it may offer the
possibility of detecting persons with impaired glucose
regulation who have already increased risk for cardio-
vascular diseases.26 The considerable number of
detected subjects with impaired glucose regulation im-
pels to a proactive approach of health care providers
in order to reduce their cardiovascular risk.27
It should be noted that Dutch GPs are not accus-
tomed to perform the OGTT in daily practice. Conse-
quently, diagnosis of diabetes will be missed in those
who have only diabetic post-load glucose values. How-
ever, this is likely a relatively small group. In our four-
step screening programme, of the 747 persons with
non-diabetic fasting glucose values who were invited
to undergo the OGTT, eventually only 35 were diag-
nosed with diabetes (although it is assumable that this
small number partially can be explained by the high
proportion of subjects who did not attend the OGTT).
In summary, the yield of population-based screening
for diabetes in the Netherlands was less than expected.
Given the decreasing prevalence of undiagnosed dia-
betes and the availability of well-organized general
practices regarding diabetes care in the Netherlands,
case finding might be more appropriate for detecting
unrecognized diabetic patients than population-based
screening.
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